Syngene International Limited Stock Bombay S.E.
Equities
SYNGENE
INE398R01022
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
695 INR | -0.77% | +1.13% | -1.02% |
Sales 2024 | 34.89B 419M | Sales 2025 * | 38.24B 460M | Capitalization | 279B 3.35B |
---|---|---|---|---|---|
Net income 2024 | 5.1B 61.28M | Net income 2025 * | 5.67B 68.18M | EV / Sales 2024 | 7.73 x |
Net cash position 2024 | 9.35B 112M | Net cash position 2025 * | 9.1B 109M | EV / Sales 2025 * | 7.05 x |
P/E ratio 2024 |
55.4
x | P/E ratio 2025 * |
51
x | Employees | 6,847 |
Yield 2024 |
0.18% | Yield 2025 * |
0.21% | Free-Float | 44.65% |
Latest transcript on Syngene International Limited
1 day | -0.91% | ||
1 week | +1.13% | ||
Current month | +0.73% | ||
1 month | -1.03% | ||
3 months | -6.63% | ||
6 months | -5.73% | ||
Current year | -1.02% |
Managers | Title | Age | Since |
---|---|---|---|
Jonathan Hunt
CEO | Chief Executive Officer | 55 | 15-02-28 |
Sibaji Biswas
DFI | Director of Finance/CFO | - | 19-12-17 |
Chairman | 71 | 94-11-17 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 71 | 94-11-17 | |
Director/Board Member | 67 | 17-07-30 | |
Jonathan Hunt
CEO | Chief Executive Officer | 55 | 15-02-28 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-23 | 695 | -0.77% | 5 986 |
24-05-22 | 700.4 | +0.91% | 33,127 |
24-05-21 | 694 | +0.73% | 9,915 |
24-05-18 | 689 | -0.24% | 2,482 |
24-05-17 | 690.6 | +0.64% | 8,975 |
Delayed Quote Bombay S.E., May 23, 2024 at 03:19 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+64.23% | 62.59B | |
-2.31% | 41.18B | |
+43.85% | 40.29B | |
-8.29% | 27.9B | |
+11.97% | 26.21B | |
-21.16% | 19.09B | |
+7.54% | 13.08B | |
+27.17% | 12.05B | |
+25.72% | 12.26B |
- Stock Market
- Equities
- SYNGENE Stock
- SYNGENE Stock